Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection

Please use this identifier to cite or link to this item: https://doi.org/10.7759/cureus.41297

DC Field	Value
dc.title	Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection
dc.contributor.author	Khan, Behram A
dc.contributor.author	Pagsinohin, Marlyn
dc.contributor.author	Lu, Lucy M
dc.contributor.author	Tan, Pauline
dc.contributor.author	Teo, Rachel
dc.date.accessioned	2023-07-13T06:07:42Z
dc.date.available	2023-07-13T06:07:42Z
dc.date.issued	2023-07-03
dc.identifier.citation	Khan, Behram A, Pagsinohin, Marlyn, Lu, Lucy M, Tan, Pauline, Teo, Rachel (2023-07-03). Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection. Cureus. ScholarBank@NUS Repository. https://doi.org/10.7759/cureus.41297
dc.identifier.issn	2168-8184
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/243068
dc.publisher	Springer Science and Business Media LLC
dc.source	Elements
dc.type	Article
dc.date.updated	2023-07-13T03:43:09Z
dc.contributor.department	DEAN'S OFFICE (MEDICINE)
dc.contributor.department	MEDICINE
dc.description.doi	10.7759/cureus.41297
dc.description.sourcetitle	Cureus
dc.published.state	Published
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
Final publication Evusheld SG DCs.pdf	Published version	513.41 kB	Adobe PDF	OPEN	Published	View/Download

Check